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Abstract: Biopolymer coated magnetite nanoparticles (MNPs) are suitable to fabricate biocompatible
magnetic fluid (MF). Their comprehensive characterization, however, is a necessary step to assess
whether bioapplications are feasible before expensive in vitro and in vivo tests. The MNPs were
prepared by co-precipitation, and after careful purification, they were coated by chondroitin-sulfate-A
(CSA). CSA exhibits high affinity adsorption to MNPs (H-type isotherm). We could only make
stable MF of CSA coated MNPs (CSA@MNPs) under accurate conditions. The CSA@MNP was
characterized by TEM (size ~10 nm) and VSM (saturation magnetization ~57 emu/g). Inner-sphere
metal–carboxylate complex formation between CSA and MNP was proved by FTIR-ATR and XPS.
Electrophoresis and DLS measurements show that the CSA@MNPs at CSA-loading > 0.2 mmol/g
were stable at pH > 4. The salt tolerance of the product improved up to ~0.5 M NaCl at pH~6.3.
Under favorable redox conditions, no iron leaching from the magnetic core was detected by ICP
measurements. Thus, the characterization predicts both chemical and colloidal stability of CSA@MNPs
in biological milieu regarding its pH and salt concentration. MTT assays showed no significant
impact of CSA@MNP on the proliferation of A431 cells. According to these facts, the CSA@MNPs
have a great potential in biocompatible MF preparation for medical applications.
Keywords: magnetite; chondroitin-sulfate; adsorption; core-shell nanoparticles; surface complexation;
surface spectroscopy; chemical stability; coagulation kinetics; colloidal stability; MTT assays
1. Introduction
Superparamagnetic nanoparticles (e.g., maghemite, magnetite, and cobalt-ferrite), usually in
organic solvent or water based ferrofluid formulations, are among the most promising nanoparticle
systems for both engineering and biomedical applications [1–14]. The organic solvent based magnetic
fluids (MFs) are used in industrial and economic applications, e.g., in high performance HiFi systems [12],
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hard disks [13], or seals operating under extreme conditions [8,14]. The water based magnetic fluids
are planned for biomedical applications in modern medicine in both diagnostics and in therapy, such as
magnetic resonance imaging (contrast agent in MRI), magnetic particle imaging, targeted drug delivery,
and magnetic hyperthermia therapy [2–7,9–11,15–17]. These in vivo applications require that MFs are
non-toxic and that the magnetic particles are sufficiently uniform in size, well-dispersed in aqueous
media, and chemically and colloidally stable under in vivo conditions (e.g., in blood: pH ~7.2–7.4,
~150 mM salt concentration and the presence of proteins).
To fulfill these criteria, the magnetic nanoparticles must be coated [18,19], for example, by small
organic molecules (e.g., citric acid [10,20–22] and oleic acids [23,24]), neutral polymers (e.g., natural
dextran [20,25], synthetic polyethylene-glycol [20,25–27]), or by polyelectrolytes (e.g., synthetic
polyacrylic acid (PAA) [20–22]). The enhanced colloidal stability of magnetic nanoparticles can
be achieved by electrostatic (e.g., citric acid coating), steric (e.g., dextran coating) or electrosteric
stabilization (e.g., polyacrylic acid coating) [28,29]. The thicker layer of a polyelectrolyte shell provides
better electrosteric stability as compared to the stabilization by the adsorbed small molecules of citric
acid dissociated at pH > 4 [21].
Usually, the non-toxic magnetite nanoparticles (MNPs) are used to prepare biocompatible magnetic
fluids. There are two typical ways to coat MNPs [20]. One of these is the in situ coatings where the
nanoparticles are coated during the precipitation of iron oxide [20,30–33]. The other is the post-synthesis
coating method, in which the surface of the previously synthesized and purified magnetic particles are
modified [19–22].
Polysaccharides are the most promising natural stabilizing agents for magnetic nanoparticles [34],
e.g., dextran-coated iron oxide (Ferumoxides and Ferumoxtran-10) and carbo-dextran-coated iron
oxide (Ferucarbotran) are well known products for biomedical applications [22,35]; furthermore,
chitosan [36,37] and chondroitin-sulfate (CS) [38] with polyelectrolyte character are suitable for this
purpose too.
Chondroitin-sulfate (CS) is a sulfated natural polysaccharide. One repeating unit of CS is comprised
of a glucuronic acid and an N-acetyl-galactoseamine ring, the latter modified by sulfate groups
replacing –OH groups. There are several types of CS depending on the positions and the quantities
of the –SO3H groups, chondroitin-sulfate-A (CSA, chondroitin-4-sulfate), and chondroitin-sulfate-C
(CSC, chondroitin-6-sulfate) being the most common types [39]. One repeating unit of CSA
contains two dissociating groups, a –COOH and a –SO3H group, with significantly different
protonation/deprotonation properties. The strongly acidic sulfate groups are fully deprotonated
in a wide pH-range [40,41], while the –COOH groups are characterized by pH-dependent dissociation
with pKβ-glucuronic acid ~2.9 [42]. Regarding the biomedical usability, chondroitin sulfate proteoglycans
play a key role in tumor growth, since the negatively charged CS chains interact with a large number
of ligands and receptors, and activate signaling pathways, which stimulate tumor growth. However,
some modified CSs such as oversulfated CS are known as potential anticancer agents [43]. It is highly
probable that CSA coated MNPs are able to accumulate near the tumor, thereby efficiently acting as a
contrast agent in MRI and locally in magnetic hyperthermia.
The chondroitin-sulfate iron colloid complex is a therapeutic agent for iron deficiency anemia
(Blutal, Dainippon Pharmaceutical Co.), which has been marketed for more than 30 years [44,45].
There are patents for magnetic nanoparticles prepared in the presence of CS for a feasible
MRI contrast agent [33,46], and several other publications can be found on magnetite coated by
chondroitin-sulfate [30,47,48]. Novel CSA-coated core–shell magnetite nanoparticles (CSA@MNP)
were recently prepared successfully by a well-defined post-synthesis coating method [49]. The resulting
magnetic fluid has had sufficient colloidal stability for in vivo applications, but its exact physical,
physicochemical, and colloidal properties have not been explored comprehensively. The qualitative
and quantitative characterization of shell formation on the magnetic core; the determination of the
bond formation between CSA and MNP surface; the quantitative optimization of coating to stabilize
MNPs efficiently; the characterization of core-passivation efficiency; the determination of particle
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charge; and the salt tolerance measurements of CSA-coated MNPs are effective and inexpensive tools
to optimize the MNP coating process, and to prove the feasibility of biological applicability of the
prepared materials [22].
The fundamental aim of this work is the comprehensive characterization of CSA@MNPs prepared
by a post-synthesis coating method, and designed for biomedical applications. First, we synthesized
the magnetic core by co-precipitation, and clarified the composition of CSA by TG and potentiometric
acid-base titration. Then, we studied quantitatively the adsorption of CSA on MNPs by analyzing the
adsorption isotherm, and characterized the CSA@MNP particles by TEM and VSM techniques. Next,
we identified the chemical bonds between the MNPs and CSA by FTIR-ATR and XPS spectroscopies.
After that, we studied the pH-dependent surface charging and aggregation properties of the CSA@MNP
particles, and tested the capability of magnetic fluids for biomedical applications by coagulation
kinetics studies, and also measured the dissolved iron-content responsible for the damage caused
by ROS in vivo. Finally, we investigated the toxicity of the optimized CSA@MNPs in cytotoxicity
experiments. We would like to emphasize that the characteristic material properties investigated
here are very closely related to possible biological applications. Nel et al. [50] have demonstrated
that different propensities of bionanointerfaces such as surface charge hydrophobicity (dispersibility)
of particles correlate well with the results of toxicity tests in biological systems. Our studies on
MNPs’ hemacompatibility [51] have proved that colloidal stability testing at biorelevant pH and salty
conditions can reveal blood incompatibility, that ‘promises’ fatal outcomes in vivo such as thrombosis
in the case of intravenous administration.
2. Results and Discussion
2.1. Adsorption of CSA on MNP
The adsorption isotherm of CSA on MNP determined by the batch method using both density
measurement and enzymatic digestion followed by UV-absorption concentration determination is
presented in Figure 1. The detection limit of the well-known enzymatic digestion measurements was
~1 mmol/L, so density measurements were used to determine the adsorption isotherm at equilibrium
CSA concentrations lower than that. The two different series of results fit well together.Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 4 of 20 
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These values express mmoles of the CSA repeating unit, so the amount of the negative charges 
carried by adsorbed CSA is about twice of them, since the total amount of negative charges at the pH 
and ionic strength of the experiments is 1.9 mol/mol of repeating units (see Figures S1–S3 for details). 
The shape of the CSA isotherm is similar to that of poly(acrylic acid-co-maleic acid) copolymer 
(PAM) at the same pH and ionic strength [19], but the adsorbed amounts are much smaller (the 
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amount of negatively charged functional groups on the unit length of the chain) can be estimated 
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polyelectrolytes. At pH ~6.3 and 10 mM NaCl, the calculated charge density of the CSA chain is 
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donor groups serving as ligands for adsorption such as carboxylate, sulfate, alcoholic hydroxyl, or 
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together with the relatively wide ring structure of the CSA backbone gives rise to a significant steric 
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In the photos of CSA@MNP samples (inserted in Figure 1), the signs of aggregation (large 
particles on the glass surface and partial sedimentation) can be seen even at high equilibrium 
concentration in the range of the adsorption plateau. The CSA prepared from bovine trachea 
contains a small amount of cetylpyridinium chloride (CPCl) contamination [58,59], which can be 
adsorbed on MNP resulting in the partial hydrophobization of the surface and the aggregation of 
CSA@MNP samples. This was proved by UV-measurements. The characteristic absorption of CPCl 
at ~260 nm [59–61] was detected in the solution of CSA, and it was absent in the equilibrium 
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Figure 1. Adsorption isotherm of chondroitin-sulfate-A (CSA) on magnetite nanoparticles (MNP) at
pH ~6.3 and 10 mM NaCl. With increasing CSA concentration, the colloidal state of samples changes
characteristically from aggregated to stable, as seen in the vials. Stable CSA@MNP (see the inserted
photos) can only be prepared under accurate conditions. (The amount of CSA is expressed through the
number of repeating units in mmol. The line is drawn as a guide for the eye).
The point of zero charge (PZC) of naked MNPs is at pH ~8.0. At pHs lower than the PZC,
the surface charge of MNP is positive due to the presence of ≡Fe–OH2+ groups on the surface, while the
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particles are negatively charged above the pH of PZC because of the ≡Fe–O− groups [52]. At pH ~6.3
and 10 mM NaCl, the amount of the positive charge on MNPs is ~0.05 mmol/g from acid-base
titration [19]. It is not enough to electrostatically stabilize the particles; therefore, the naked magnetite
is aggregated and settled, as seen in the first vial of Figure 1. Above ~0.2 mmol/g of CSA-addition,
the CSA-coated magnetite nanoparticles become well dispersed (see in the third vial on Figure 1) due
to the electrosteric stabilization effect of the adsorbed polyelectrolyte (see the characterization of CSA
dissociation in Figures S1–S3).
CSA has an H-type (high-affinity) adsorption isotherm on the MNP surface with a high-affinity
limit of adsorption at ~0.06 mmol/g (close to the amount of the positive charge on MNP ~0.05 mmol/g)
and the plateau is reached at ~0.10 mmol/g at relatively low equilibrium concentration. These values
express mmoles of the CSA repeating unit, so the amount of the negative charges carried by adsorbed
CSA is about twice of them, since the total amount of negative charges at the pH and ionic strength
of the experiments is 1.9 mol/mol of repeating units (see Figures S1–S3 for details). The shape of the
CSA isotherm is similar to that of poly(acrylic acid-co-maleic acid) copolymer (PAM) at the same
pH and ionic strength [19], but the adsorbed amounts are much smaller (the high-affinity limit is at
~0.3 mmol/g, and the plateau is at ~0.9 mmol/g for the PAM adsorption). The large differences can be
explained by the molecular structure of CSA. The charge density (i.e., the amount of negatively charged
functional groups on the unit length of the chain) can be estimated from the molecular structure and
the pH- and ionic strength-dependent charging of the polyelectrolytes. At pH ~6.3 and 10 mM NaCl,
the calculated charge density of the CSA chain is about –2.1 nm−1 (i.e., there are 0.95 –SO3− and 0.95
–COO− groups corresponding to the ~0.9 nm long repeating unit [53]), which is much smaller than
the ~ –4.5 nm−1 characteristic for PAM (i.e., the repeating unit of PAM is ~0.4 nm long and it contains
3 –COOH groups, the degree of dissociation of which is 0.6 [19]). The molecular structure of CSA is
even more complex; it contains several potential donor groups serving as ligands for adsorption such
as carboxylate, sulfate, alcoholic hydroxyl, or amide groups [54–57]. In addition, the chain of CSA is
much less flexible than that of PAM, which together with the relatively wide ring structure of the CSA
backbone gives rise to a significant steric constraint of the adsorption.
In the photos of CSA@MNP samples (inserted in Figure 1), the signs of aggregation (large particles
on the glass surface and partial sedimentation) can be seen even at high equilibrium concentration in
the range of the adsorption plateau. The CSA prepared from bovine trachea contains a small amount
of cetylpyridinium chloride (CPCl) contamination [58,59], which can be adsorbed on MNP resulting
in the partial hydrophobization of the surface and the aggregation of CSA@MNP samples. This was
proved by UV-measurements. The characteristic absorption of CPCl at ~260 nm [59–61] was detected
in the solution of CSA, and it was absent in the equilibrium supernatant of CSA@MNP samples even
at high CSA concentration. The presence of cetylpyridinium chloride is not favorable for preparing
stable CSA@MNP samples, but this problem can be solved by production under accurate conditions
(specific pH, ionic strength, and ultrasonication).
2.2. Size and Magnetic Property of Magnetic Core in CSA@MNP
These propensities of MNPs’ product for biomedical use are crucial because excretion of NPs
depends on their size, and their efficacy in MRI or hyperthermia is based on the magnetic character.
The TEM image and the specific magnetization curve of the stable CSA@MNP particles are presented in
Figure 2. The TEM image of the naked MNP below the coated sample is also shown for direct comparison.
Due to the presence of surface coating that prevents the close aggregation of nanoparticles [62],
many white gaps can be identified among MNPs in the TEM image of CSA@MNP sample (Figure 2a
top), especially compared directly to the naked one (Figure 2a bottom). The difference in the degree of
aggregation is clearly visible in the TEM images. The aggregates containing mostly the larger primary
particles are probably present in the suspension of the naked sample, which are dispersed because of
the stabilizing effect of CSA-coating. The latter is also supported by a limited increase in the average
particle size of the CSA@MNP sample related to that of the naked one, as shown in the insets of TEM
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images in Figure 2a. It should be noted that only discrete particles can be taken into account when
determining average size distribution.
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Figure 2. (a) TEM picture and particle size distribution of CSA@MNP nanoparticles at pH ~6.3 (top) and
that of naked MNPs (bottom); (b) specific magnetization curve measured in the dispersion CSA@MNPs
at room temperature (10 g/L in water at pH ~6.3). (The Ms is assigned only for illustration.).
The magnetization curve of CSA@MNPs in fluid media (Figure 2b) shows superparamagnetic
behavior at room temperature, as it is expected for magnetite nanoparticles of small sizes, of about 10
nm that are surface coated by a non-magnetic organic layer. The measured magnetization values were
converted to specific magnetization, using the exact amount of magnetite in the sample. The mass
of the CSA and medium was not involved in this calculation. The saturation magnetization (MS)
was obtained by extrapolation to an infinite field in an M vs. 1/H2 plot [63]. Thus, the MS of the
superparamagnetic CSA@MNPs is 56.9 emu/g related to the exact amount of magnetite. This value is
in the range of 53–58 emu/g measured for the polyacrylic acid-coated MNPs, and suggests no decrease
in the size of the magnetic core due to iron dissolution on CSA adsorption, contrary to that observed in
citrated MNPs (~42 emu/g at high citric acid-loading) [22].
2.3. Binding of CSA on MNPs
FTIR-ATR analysis was used to characterize the bond formation on ≡Fe-OH sites. Figure 3 shows
the IR absorption spectra of pure MNP, CSA, and CSA-coated MNP. The positions of characteristic
bands are collected in Table 1.
In the spectrum of pure MNP, two characteristic bands are present, i.e., the H-bonded OH-stretching
at ~1620 cm−1 [64] and the Fe−O band at ~548 cm−1 [65,66]. The Fe−O band shifts to higher wavenumber
(~559 cm−1) upon CSA adsorption.
The characteristic bands of deprotonated sulfate groups (–O–SO3−) in the spectrum of CSA are
the S = O and C−O−S stretching vibrations at ~1260 cm−1 and ~856 cm−1, respectively [57,58,67,68].
The position of the C−O−S vibration confirms that the current CS sample is almost completely CSA [58].
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The characteristic bands of –O–SO3− remained unchanged during the adsorption, so the sulfate groups
are not involved in the adsorption [57]. The vibration of amide groups at ~1560 cm−1 [57,64,67] as
well as the vibrations of the alcoholic hydroxyl groups and pyranose rings at 1234 cm−1, 1414 cm−1,
1055 cm−1, 1035 cm−1, and 925 cm−1 [67] do not change during the adsorption, so these groups are also
not able to bind on the magnetite surface.
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Figure 3. FTIR-ATR spectra (absorbance is given in arbitrary units) of CSA, magnetite (MNP), and
CSA-coated magnetite (CSA@MNP) in the 800−1900 cm−1 (left side) and in the 400−800 cm−1 (right
side) range. Samples were dried on the diamond crystal from solution/dispersions at pH ~6.3.
Table 1. Characteristic IR bands and their shifts (cm−1) due to the CSA-adsorption on magnetite
nanoparticles at pH ~6.3 and 10 mM NaCl.
MNP CSA CSA@MNP ∆ν *
Fe–O (≡Fe–OH) 548 559 11
C = O (–COOH) - - -
C–O (sym., –COO−) 1375 1379 4
C–O (asym., –COO−) 1612 1630 18
C–O–S (–O–SO3−) 856 856 0
S = O (–O–SO3−) 1260 1260 0
* ∆ν = νadsorbed−νfree.
The characteristic band of protonated carboxyl groups (−COOH) is the C = O stretching band
around ~1740 cm−1 [64,69], which does not appear in the spectrum of CSA. However, the deprotonated
carboxylates provide the asymmetric and symmetric vibrations of the −COO− resonant structure
around ~1612 cm−1 and ~1379 cm−1 [64,67–69]. These data indicate that the carboxyl groups of CSA
are almost completely deprotonated (−COO−) at pH ~6.3 and 10 mM NaCl. This is also expected on
the basis of titration results (Figure S3), namely that the amount of protonated carboxylates at pH ~6.3
and 10 mM NaCl is negligible: 0.05 mol/mol of repeating units.
The C = O stretching band does not appear even in the spectrum of CSA-coated MNP, so the
protonated –COOH groups are not involved in the mechanism of adsorption. Therefore, there is no
H-bond formation between the CSA and MNP. However, the asymmetric and symmetric vibrations of
C−O in the COO− groups are shifted significantly (see ∆ν values in Table 1) after adsorption, indicating
the formation of direct metal-carboxylate complexes [19,69]. Both the neutral (≡Fe–OH) and positively
charged (≡Fe–OH2+) surface groups of MNPs can be involved in the formation of this inner-sphere
metal–carboxylate complexes:
≡Fe-OH + −OOC-R→≡Fe-OOC-R + OH− (1)
≡Fe-OH2+ + −OOC-R→≡Fe-OOC-R + H2O (2)
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This type of complex-formation can explain the H-type isotherm of CSA adsorption on the MNP.
The high resolution XPS spectra of Fe, C, O, N, and S in the CSA@MNP sample are shown
in Figure 4. The peaks were deconvoluted into the components. The fitting parameters of the
deconvolution, i.e., the peak positions (binding energy) and the full width at half-maximum (fwhm)
together with the atomic concentrations calculated from the peak areas are given in Table 2. In bulk
magnetite (Fe(III)2Fe(II)O4), the theoretical Fe3+/Fe2+ atomic ratio is 2.0. However, this value decreased
to 1.4 in the case of CSA-coated MNPs, as calculated from the Fe3+ and Fe2+ 2p peaks, which shows
the reduction of iron at the MNP surface in the presence of CSA polysaccharide.
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Figure 4. XPS spectra of Fe 2p, C 1s, O 1s, N 1s, and S 2p core levels from CSA@MNPs sample at
pH ~6.3 and 10 mM NaCl.
The chemical structure of the CSA is very complex, and thus the assignment of the electron binding
energies determined from the deconvolution of the XPS peaks belonging to the moieties of adsorbed
CSA is difficult. The N 1s peak and the S 2p peaks were found at 399.67 eV, 169.95 eV, and 166.77 eV,
respectively. The best fit for C 1s spectrum was obtained with four components: The peaks at 284.61 eV
and 285.90 eV were assigned to C-C, C-H and C-O, C-N, respectively; the peaks at 288.29 eV and
289.48 eV were assigned to N-C = O, C-O(-SO3−) and O-C = O. The ratio between the moieties with
lower (284.61 eV and 285.90 eV) and higher (288.29 eV and 289.48 eV) binding energies calculated
from the atomic concentrations of C 1s peaks is 4.1 (Table 2), while the same ratio calculated from the
molecular structure of CSA is 3.7. The O 1s peak at 530.51 eV was assigned to C-O(-C), C-O(-H), and
C-O(-S), and that at 532.43 eV to O-C = O, N-C = O, and -SO3−. The deconvoluted peak at 536.11 eV is
the sign of adsorbed water [62,70,71]. The ratio between the atomic groups with lower (530.51 eV)
and higher (532.43 eV) binding energy calculated from the atomic concentrations of O 1s peaks is
1.49, while that calculated from the molecular structure of CSA is 1.37. The results show that the
relative amount of the bonds with higher electron binding energies is smaller in the adsorbed CSA.
This observation also confirms the formation of inner-sphere metal–carboxylate complex.
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Table 2. Assignment of peaks in the XPS spectra of the CSA@MNPs together with binding energies
(position, eV), peak full width at half maximum (fwhm, eV), and atomic concentration percentages
(atomic conc, (%).
Peak Name Position (eV) fwhm (eV) Atomic Conc (%)
Fe2+ 2p3/2 710.46 3.410 5.629
Fe3+ 2p3/2 712.98 6.000 7.950
Fe2+ 2p1/2 723.66 3.882 5.450
Fe3+ 2p1/2 725.78 6.000 7.697
Fe3+ satellite 2p3/2 719.92 4.075 1.184
Fe2+ satellite 2p3/2 718.19 4.374 1.038
Fe3+ satellite 2p1/2 733.06 4.627 1.507
Fe2+ satellite 2p1/2 729.03 4.649 0.690
C 1s; C-C, C-H 284.61 2.147 6.221
C 1s; C-O, C-N 285.90 3.121 9.037
C 1s; N-C = O, C-O(-SO3−) 288.29 2.218 2.935
C 1s; O-C = O 289.48 1.929 0.794
O 1s; Fe-O, In-O 529.49 1.746 11.066
O 1s; C-O 530.51 2.802 20.488
O 1s; O-C = O, N-C = O,
-SO3− 532.43 3.838 13.709
O 1s; H2O 536.11 2.356 2.342
N 1s; N-H 399.67 2.814 1.717
S 2p3/2; -SO3− 169.95 2.230 0.271
S 2p1/2; -SO3− 168.77 1.909 0.277
2.4. The Effect of CSA Adsorption on the Charge State and Aggregation of MNPs
The electrokinetic potential of the nanoparticles and the adsorbed amount of CSA on MNPs
at pH ~6.3 and 10 mM NaCl are plotted as a function of CSA-loading in Figure 5. As was already
discussed in the adsorption of CSA on MNP section, the MNPs are positively charged and settled
under this condition, as seen in the first picture inserted in Figure 5. The electrokinetic potential of
naked MNPs is ~ +25 mV, and this value decreases with the increasing amount of added CSA carrying
negative charges. The charge neutralization occurs at ~0.035 mmol/g of CSA-loading, and the further
addition of CSA causes charge reversal, and increases the absolute value of the negative electrokinetic
potential. The CSA@MNP particles become fully dispersed at >~0.2 mmol/g of CSA addition (see
the pictures inserted in Figure 5) due to the electrosteric stabilization supported by the large absolute
values of the electrokinetic potential, −40 mV similarly to that published before [49].
The isoelectric point (IEP, at which the net charge of CSA@MNP is zero) is at ~0.035 mmol/g
of added CSA, which is lower than the high-affinity limit of adsorption (~0.06 mmol/g in Figure 1)
meaning that practically all added CSA is adsorbed from the equilibrium solution phase. According
to the degree of sulfonation (0.95 determined by TG Figure S1) and degrees of dissociations (~1.0 for
–SO3H and ~0.95 for –COOH groups determined by potentiometric acid-base titration Figures S2 and
S3) one mole of repeating units of CSA contains 0.95 mol –SO3− and 0.95 mol -COO− groups under
this condition. Thus, at the IEP, the total amount of charges on adsorbed CSA related to MNP is
~–0.067 mmol/g. This adsorbed negative charge slightly overcompensates the ~0.05 mmol/g value of
the original positive charge of MNPs [19]. Under the electroneutrality condition of the isoelectric point,
the excess negative charge introduced by CSA adsorption is neutralized by definition. The FTIR spectra
showed the formation of direct metal-carboxylate bonds (Equations (1) and (2)), and the electrokinetic
potential results also show that both the positively charged surface groups (Equation (2)) and the
neutral surface sites (Equation (1)) are simultaneously involved in the formation of the inner-sphere
metal–carboxylate complexes. According to the reaction of Equation (1), part of the CSA is neutralized
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in the course of adsorption without decreasing the original positive charge of the MNP surface, the latter
process being responsible for the apparent charge overcompensation.Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 9 of 20 
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Figure 5. Effect of CSA-addition on the charge state of MNPs and the colloidal stability of the dispersions
(inserted photos) at pH ~6.3 and 10 mM NaCl. The adsorption and the electrokinetic potential data are
shown. (Lines are drawn as guides for the eye).
The pH-dependent colloidal stability of MNPs with increasing CSA-loadings was monitored by
the measurements of average hydrodynamic diameter and electrokinetic potential at 10 mM NaCl.
The IEP values at different CSA-loadings and the pH ranges of nanoparticle aggregation have been
collected in Table 3. Without CSA, the IEP is at pH ~8, and the dispersions of naked magnetite are only
colloidally stable at pHs below 5 or above 10. By increasing CSA addition, the IEP shifts gradually
to more acidic pH. At trace CSA-loading (0.05 mmol/g), the CSA@MNP particles aggregate in the
whole pH-range studied here due to the patch-wise adsorption of oppositely charged CSA on MNP.
A similar observation was made in humic acid adsorption on MNPs [52]. Further CSA addition leads
to narrowing the pH-range of aggregation around the IEP, and the CSA@MNP dispersions become
stabilized in the whole pH-range studied at loadings above ~0.2 mmol/g [49].
Table 3. Effect of the CSA-l ading the isoelectric point (IEP) and the pH-range of MNPs’ aggregation
at 10 mM NaCl.
CSA-Loading (mmol/g) pH of IEP pH-Range of Aggregation
0.00 ~8 ~5 - ~10
0.05 ~6 ~3 - ~10
0.10 ~4 < ~5
0.20 < 3 < ~3.5
0.40 < 3 < ~3
2.5. Salt Induced Aggregation of CSA@MNP at pH ~6.3
The salt olerance of naked and CSA-coat d MNPs was characterize by stability rati (W)
determined at different NaCl concentrations i co gulation kinetics experiments at near physiological
pH ~6.3. The stability plot (the logarithm of stability ratio (lo 10 W) as a function of the logarithm
of salt concentration (log10 NaCl)) is shown i Figure 6. The dashed line refers to ur previous results
for PAM-coated MNPs [19] added here for comparison.
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red a rows) of MNPs in the absenc of CSA coating (open triangle symbols) and in the presence of 0.1,
0.2, nd 1.0 mmol/g CSA (diamond symbols), me sured at pH ~6.3. The previous results of PAM-coated
MNPS with 1.2 m ol COOH/g MNP loa ing [19] (dashed line) re recalled her fo comparison.
The dispersion’s salt tolerance, i.e., the smallest amount of salt inducing fast coagulation (log10
W = 0), is represented by the values of critical coagulation concentration (CCC) [49,72,73]. The CCC
determined as the intercept of the straight line of the slow coagul tion regime (log10 W > 0) with the
x-axis shifts g adually from ~1 mM for naked MNP to ~80, ~150, a d ~500 mM at CSA-loading 0.1, 0.2,
and 1.0 mmol/g, respectively. Details re given in Figure S4.
The re istance gainst physiological concentration (CCC > mM) is achieved at the CSA-addition
of ~0.2 mmol/g cor onding to he dsorb d amount of CSA close to the saturation level
(~0.11 mmol/g). Thus, the equilibr um concentration of the non-adsorbed CSA low (~1 mmol/L),
which is advantageous for possible bioapplication in the future. The salt tolerance of CSA@MNP
particles reaches maximum (~500 mM) at ~1.0 mmol/g of added CSA.
2.6. Chemical Stability of MNP Coated with CSA
Besides the redox transformation of magnetite to maghemite during storage, iron leaching may
occur from any MNP products designed for biomedical applications. The exclusion of the leaching is
very important, since a high amount of dissolved iron ions can hurt the living systems through oxidative
stress [74–76]. The chemical stability of CSA@MNP systems was tested in iron dissolution experiments.
The dissolved iron was determined in the equilibrium supernatant of aqueous dispersions in 10 mM
NaCl solution at pH ~6.3 after one day of adsorption and careful removal of MNPs. As illustrated in
Figure 7, the concentration of dissolved iron remains under the detection limit of ICP measurement
even at a high equilibrium concentration of CSA, while a significant amount of iron was dissolved in
the presence of citric acid (CA) as data recalled from our previous paper [22]. Based on these results,
we can state that the CSA layer protects the surface of magnetite, and hinders not only corrosion,
but also oxidation of MNP, as is also proven by XPS data. Therefore, CSA guarantees good chemical
stability for MNP.
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detection limit of iron).
2.7. Testing Toxicity of CSA@MNP
While the low toxicity of negatively charged nanoparticles such as CSA@MNPs in the wide
pH range is well-known, it is worth investigating it in vitro [5]. The MTT assays were selected using
a human cancer cell line. The results of the cytotoxicity tests are seen in Figure 8. The extent of
proliferation inhibition is insignificant so the CSA@MNPs exerted no substantial action on the growth
of A431 human cancer cells. The MTT method applied here is widely used for qualifying potential
anticancer agents. While the performed MTT assay cannot be a substitute for comprehensive preclinical
toxicological evaluation, it indicates that the CSA@MNP preparation is probably non-toxic, because
cell killing or growth inhibitory action was not detected.
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3. Materials and Methods
3.1. Materials
The magnetite nanoparticles were synthesized by co-precipitation, as previously published [19,21,22],
the FeCl2, FeCl3 salts, and NaOH were analytical grade reagents obt ined from Molar, Hungary. The
synthesized iron oxid wa identified s magnetite based on the X-r y diffractio pattern (JCPDS
datab se [77]), characteristic black color, and strong magnetism. The mean diameter of the MNPs
det rmined by transmi sion ele tron microscopy, and from the broadenin of the most int nsive peak of
the XRD pattern by using the Scherrer equation was ~10 nm [22].
Th sodium-salt of chondroitin-s lfate-A (Na2CSA) was purchased from Sigma-Aldrich (pristine
Na2CSA). A small amount of chondroitin-sulfate-C can be found in this m terial. The pristine Na2CSA
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were used for the surface modification of the MNPs. In this article, the notation "CSA" is used for the
sodium–salt, ignoring the actual degree of dissociation of the carboxylic groups. The amount of CSA is
expressed through the mole of repeating di-saccharide units.
NaCl, HCl, and NaOH, analytical grade products of Molar (Hungary) were used to
adjust the pH and salt concentration in all experiments. Chondroitinase ABC from Proteus
vulgaris and bovine serum albumin were purchased from Sigma Aldrich, sodium-acetate, and
tris-(hydroxymethyl)-aminomethane were purchased from Reanal for enzymatic digestion of CSA.
Ultra-pure water from a Milli-Q RG water purification system (Millipore) was used. All measurements
were performed at 25 ± 1 ◦C except the enzymatic digestion of CSA and the incubation of cells for
cytotoxicity experiments, which were performed at 37 ± 1 ◦C.
3.2. Adsorption Experiment
The adsorption isotherm of CSA at the MNP surface was determined at pH = 6.3 ± 0.3 and
10 mM NaCl. We used the batch method, in which the MNPs were equilibrated for 24 hours with CSA
solutions of concentration between 0.0 and 10 mM at a solid/liquid ratio of 10 g/L. The pH was set at
the start of the adsorption. The solid phase was separated by centrifuging at 14,500 rpm for 1 hour
(Eppendorf, MiniSpin plus, Germany).
The equilibrium concentration of the supernatants was determined by two different methods. First,
the higher equilibrium concentrations were determined by enzymatic digestion (chondroitinase ABC
from Proteus vulgaris, Sigma Aldrich, Germany) according to the enzymatic assay of chondroitinase
ABC (Enzyme Commission Number 4.2.2.4) [78] followed by the absorbance measurement at 232 nm
in an USB4000 spectrometer (Ocean Optics). The lower equilibrium concentrations were determined
by density measurements (DMA58, Anton Paar, Austria).
The adsorbed amount of CSA (nσCSA) was calculated using the material balance equation
for adsorption, nσCSA = (V/m)·∆cCSA, where V/m is the solution/adsorbent phase ratio (L/g) and
∆cCSA is the change in the CSA concentration in the aqueous phase due to the adsorption (mmol/L).
The adsorption isotherm was plotted in the function of the equilibrium CSA concentration.
3.3. Transmission Electron Microscopy (TEM)
A Philips CM-10 transmission electron microscope supplied with a Megaview-II camera was used
to take the TEM micrographs of magnetite nanoparticles loaded with 0.4 mmol/g CSA. The accelerating
voltage of 100 kV was applied; the maximum resolution of the instrument is 0.2 nm. One drop of
the highly diluted sol was dried on to a Formwar-coated copper. The average size distribution was
determined by evaluating 100 particles using the JMicroVision 1.2.7 software.
3.4. Magnetic Measurement (VSM)
A vibrating sample magnetometer VSM 880 (DMS/ADE Technologies-USA) was used to measure
the magnetization curve of CSA@MNP particles with 0.4 mmol/g CSA-loading. The experiment
was taken at the RCESCF-UP Timisoara, and the analysis was performed at room temperature on
stable sol at 1% by weight, which means that 100 g magnetic fluid contains 1 g magnetite (without
CSA). The maximum of the applied field was ~12000 Oe. After the measurement, the value of
specific magnetization was calculated by using the exact amount of MNP without CSA and medium.
The saturation magnetization (MS) value characteristic for the magnetite nanoparticles was calculated
by extrapolation to an infinite field in an M vs. 1/H2 plot [63].
3.5. Infrared Spectroscopy (FTIR-ATR)
FTIR-ATR spectra were recorded with a Bio-Rad Digilab Division FTS-65A/896 spectrometer with
DTGS detector, using a Harrick’s Meridian Split Pea Diamond ATR accessory. The absorbance of
the samples was measured in single reflection mode over the 400−4000 cm−1 range (with resolution
of 2 cm−1), accumulating 256 scans. Magnetite dispersion, aqueous CSA solution, and CSA@MNP
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suspension were dried on the crystal surface. The CSA@MNP was loaded with 0.2 mmol/g CSA,
the pH of all samples was set to 6.3 ± 0.3, and the ionic strength was 10 mM (NaCl). The background
spectra were measured on clean and dry diamond crystal.
3.6. X-ray Photoelectron Spectroscopy (XPS)
An XPS spectrometer SPECS equipped with an Al/Mg dual-anode X-ray source, a PHOIBOS 150
2D CCD hemispherical energy analyzer, and a multichanneltron detector with a vacuum maintained at
1 ×10 −9 Torr was used to record the XPS spectra. The Al Kα X-ray source (1486.6 eV) was operated at
200 W. The XPS survey spectra were recorded at 30 eV pass energy and 0.5 eV/step. The high-resolution
spectra for the individual elements (Fe, C, O, N, and S) were recorded by accumulating 10 scans at
30 eV pass energy and 0.1 eV/step. MNP nanoparticles loaded with 0.2 mmol/g CSA were used for
the experiment. The suspension was prepared at pH = 6.3 ± 0.3 and 10 mM NaCl. The CSA@MNP
particles were dried on an indium foil, and the surface of the samples was cleaned by argon ion
bombardment (300 V). The spectra were recorded before and after the cleaning. Data analysis and
curve fitting was performed using CasaXPS software with a Gaussian–Lorentzian product function
and a nonlinear Shirley background subtraction. The high resolution spectra were deconvoluted into
the components corresponding to particular bond types.
3.7. Dynamic Light Scattering (DLS)
The average hydrodynamic diameter (Z-Ave) of MNP and CSA@MNP particles characteristic
for their aggregation state were determined at 25 ± 0.1 ◦C using a Nano ZS apparatus (Malvern, UK)
operating in backscattering mode at an angle of 173◦. The samples were diluted to give an optimal
intensity of ~105 counts per second. To get comparable data, the dispersions were homogenized
in an ultrasonic bath for 10 s, after which 2 min relaxation was allowed before the start of the
DLS measurements. The influence of the CSA-loadings on the average hydrodynamic diameter of
CSA@MNPs was determined at pH = 6.3 ± 0.3 and 10 mM NaCl. The effect of pH variation (between 3
and 10) on the aggregation state of the bare and coated nanoparticles (i.e., at 0.0, 0.05, 0.1, 0.2, and
0.4 mmol/g CSA-loadings) was studied at 10 mM NaCl. We used the second or third-order cumulant
fit of the autocorrelation functions, depending on the degree of polydispersity.
3.8. Electrophoresis Experiments
Electrophoretic mobilities of the naked MNP and different CSA@MNP nanoparticles were
measured in a Nano ZS (Malvern, UK) apparatus with a 4 mW He−Ne laser source (λ = 633 nm)
using disposable zeta cells (DTS 1060) at 25 ± 0.1 ◦C. The zeta-standard of Malvern (−55 ± 5 mV) was
used for calibration. The measured samples were the same as those prepared for the DLS studies.
The Smoluchowski equation was applied to convert electrophoretic mobilities to electrokinetic potential
values. The accuracy of the measurements was ±5 mV.
3.9. Coagulation Kinetics Experiments
The effect of adsorbed CSA on the colloidal stability of magnetite nanoparticles was tested in
coagulation kinetics experiments at different NaCl concentrations at pH = 6.3±0.3. The CSA-loadings
were 0.1, 0.2, and 1.0 mmol/g. The change in the average hydrodynamic diameter (Z-Ave) was
measured by DLS at 25 ± 0.1 ◦C for 15 min with a resolution of 60 s. The initial slope of the kinetic
curves, i.e., dZ-Ave/dt = f(t) is proportional to the coagulation rate [49,72,73], so the stability ratio
(W) can be calculated as the ratio of the initial slopes belonging to the fast and slow coagulation,
respectively. The salt tolerance of the samples is given as the critical coagulation concentration (CCC)
obtained from the stability ratio (log10 W) vs. electrolyte concentration (log10 c) functions.
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3.10. Iron Dissolution Experiments
Chemical stability of the CSA-coated nanoparticles was characterized by the determination of the
dissolved iron in the aqueous dispersions of CSA@MNPs after 24 hours adsorption at pH = 6.3 ± 0.3
and 10 mM NaCl. The samples were selected along the adsorption isotherms: Four of them evenly
distributed in the rising part and two of them in the plateau region. The equilibrium supernatants were
separated at 500 mM NaCl by centrifuging at 13,000 rpm for 1 hour. The iron content was measured in
an Agilent 7700x ICP-MS spectrometer. Reliable iron concentration cannot be determined below the
limit of ~150 ppb.
3.11. Anti-Proliferative Assays
A431 human cancer cell line (isolated from skin) was maintained in minimal essential
medium supplemented with 10% fetal bovine serum (FBS), 1% nonessential amino acids, and an
antibiotic-antimycotic mixture. The cells were grown in a humidified atmosphere of 5% CO2
at 37 ◦C. The cell line was purchased from the European Collection of Cell Cultures (Salisbury,
UK). Cells were seeded onto 96-well plates at a density of 5000 cells/well and allowed to stand
overnight, after which the medium containing the tested agent (CSA@MNP with 0.2 mmol/g
CSA-loading) was added. Final MNP concentration in the samples varied between 0.001 and
0.1 mg/mL. After a 72 hours incubation period, viability was determined by the addition of 0.02 mL
of MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]) solution (5 mg/mL). The
precipitated formazan crystals were solubilized in dimethyl sulfoxide (DMSO) (0.1 mL), and the
absorbance was measured at 545 nm with an ELISA (enzyme-linked immunosorbent assay) reader [79].
The samples were characterized by the growth inhibition capacity expressed as a percentage.
The majority of experiments were performed at pH = 6.3 ± 0.3 and 10 mM NaCl, so we simplify
the notion of this pH value as ~6.3, and omit to note pH and ionic strength unless it has special
significance or the values are different.
4. Conclusions
In this work, CSA-coated core-shell magnetite nanoparticles were synthesized in a post-synthesis
coating process. We characterized both the mechanism of surface modification and the physical,
physicochemical, and colloidal properties of the CSA@MNPs. It turned out that the cetylpyridinium
chloride content of CSA affects the stabilization of the magnetite nanoparticles, and so accurate
conditions are required to prepare stable CSA@MNP magnetic fluid. TEM images and VSM
measurements evidenced that the size and magnetic properties of magnetite cores in CSA@MNP did not
change during the post-synthesis coating process. FTIR-ATR spectra and XPS measurements proved
that CSA forms inner-sphere metal–carboxylate complexes (≡Fe–OOC–R) on the MNP surface. This
bond formation may support the H-type adsorption isotherm, and it enables the preparation of magnetic
fluid with low equilibrium CSA concentration favorable in later in vivo applications. The CSA@MNPs
at loading above 0.2 mmol/g are electrosterically stabilized over the wide range of pH (>4, alike in
numerous biological media). The salt tolerance of CSA@MNP is sufficiently high to prevent particle
aggregation in physiological medium. There was no iron leaching and oxidation of magnetic core
owing to the excellent protective effect of the CSA layer on MNP particles. The noteworthy chemical
stability of CSA-coated MNPs, the outstanding pH and salt tolerance of the MFs accompanied by their
non-toxicity based on the MTT assays support the feasibility of chondroitin-sulfate-A-coated magnetite
nanoparticles in biomedical applications.
Obviously, further in vitro experiments are required to test the prepared magnetic fluid
(e.g., erythrocyte sedimentation rate measurements, blood smear tests, and blood cell viability
experiments to characterize the hemocompatibility), but the CSA@MNPs are favorable candidates for
biomedical applications, not only as agents in MRI diagnostics [33,45] and anticancer drug carriers [38],
but also that in magnetic hyperthermia; even the theranostic application of CSA@MNP products may
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be feasible. Furthermore, these CSA@MNP particles are suitable for preparation of biocompatible
magnetic hyaluronate-gel for a potential application as intra-articular injections in the treatment
of osteoarthritis.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/17/
4096/s1.
Author Contributions: Conceptualization, E.T. and I.Y.T; Titration, Adsorption, FTIR, I.Y.T and E.I.; Colloidal
stability, Zeta potential, Salt tolerance, I.Y.T.; MTT tests and evaluation, I.Z.; XPS spectra and evaluation, R.T.;
Writing-Original Draft Preparation, I.Y.T and M.S.; Supervision, E.T.; Analysis, Visualization, I.Y.T, M.S. and E.T.;
Writing & Editing, E.T. and I.Y.T.
Funding: This research was funded by OTKA, grant number NK 84014 and ’National Excellence Program’
TÁMOP 4.2.4. A/2-11-1-2012-0001. The APC was funded by University of Szeged.
Acknowledgments: We thank Pál Sipos for the idea to start the study with CSA, and Gábor Galbács for the ICP
measurements performed at the Department of Inorganic and Analytical Chemistry (University of Szeged), Rita
Bauer for the technical contributions during the measurement of the adsorption isotherm, Ladislau Vekas and
Oana Marinica (Research Center for Engineering of Systems with Complex Fluids, UP Timisoara) for the VSM
measurement. This article is based upon work from COST Action RADIOMAG (TD1402), supported by COST
(European Cooperation in Science and Technology).






CSA@MNP CSA coated MNP
CS Chondroitin-sulfate
CPCl cetylpyridinium chloride
TEM transmission electron microscopy
VSM vibrating sample magnetometer
FTIR-ATR Fourier transform infrared spectroscopy - attenuated total reflectance
XPS X-ray photoelectron spectroscopy
DLS dynamic light scattering
ICP inductively coupled plasma
ICP-MS inductively coupled plasma mass spectrometry
MRI magnetic resonance imaging
TG thermogravimetry
ROS reactive oxygen species
CCC critical coagulation concentration
MTT a colorimetric assay for assessing cell metabolic activity
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